Maintenance Lenalidomide in Lymphoma

NCT01575860 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

8

Enrollment

OTHER

Sponsor class

Conditions

Lymphoma

Interventions

DRUG: Lenalidomide

Sponsor

Abramson Cancer Center at Penn Medicine